Abstract
Adverse iatrogenic effects of especial relevance for antidiabetes medications include hypoglycemic episodes, major adverse cardiovascular (CV) events, cancer, bone fractures, pancreatic effects, genital/urinary tract infections, and weight gain. Here, recent clinical studies addressing safety profiles of antidiabetes medications are reviewed. On balance, new prospective and population-based studies continue to indicate that the benefits of improved glucose control outweigh the risks associated with antidiabetes medications in most patients with type 2 diabetes.
| Original language | English |
|---|---|
| Pages (from-to) | 185–195 |
| Number of pages | 11 |
| Journal | Clinical Pharmacology & Therapeutics |
| Volume | 98 |
| Issue number | 2 |
| Early online date | 2 May 2015 |
| DOIs | |
| Publication status | Published - 31 Aug 2015 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Safety of antidiabetes medications: an update'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver